Publication | Closed Access

MAP3K1 expression is associated with progression and poor prognosis of hormone receptor-positive, HER2-negative early-stage breast cancer

Cancer ResearchBreast OncologyMedicineBreast CancerPoor PrognosisMap3k1 ExpressionCancer GeneticsRadiation OncologyCancer BiologyCell BiologyCell SignalingTumor BiologyEndocrine-related Cancer